Diaverum appoints new Chief Financial Officer and Chief Strategy & Health Policy Affairs Officer
22.01.2015 13:28
Diaverum, one of the world's leading providers of nephrology care services, has appointed two top German managers to its global board. Martin E. Löffler, an internationally experienced CFO, will take over the position from Annette Kumlien, who recently moved to the role of Chief Operating Officer, on February 1st. Since January 1, 2015, Dr. Claus Biermann acts as Chief Strategy & Health Policy Affairs Officer. Both managers report directly to Dag Andersson, CEO and President of Diaverum.
“We are growing strongly and are expanding our service portfolio to include holistic care offerings,” says Dag Andersson, commenting on the changes on the board. “We have therefore also adjusted the functions on the board. The previous “Strategic Management” department was expanded to include the topics of governmental affairs and health economics.”
“Martin Löffler brings years of expertise in dynamic environments and complex structures, while we work with Dr. Claus Biermann was able to attract an industry expert with broad experience in strategy, health policy and health economics to Diaverum. The focus on the patient is also very important to both of them,” adds Dag Andersson.
Martin E. Loeffler – internationally experienced CFO
Martin Loeffler began his career in controlling and then took on the role of managing director and regional CFO at Computer 2000 after its takeover by Tech Data Corporation. From 2003 he worked as CFO in various companies such as Thiel Logistik AG, GAGFAH SA and agri.capital. Before joining Diaverum, he worked as managing director at CFO Solutions in Hamburg. Martin Löffler is a qualified business economist and holds an MBA from the University of Georgia, USA.
“Diaverum has shown impressive development in recent years and is highly valued as a partner due to its international approach and ability to adapt to local requirements. I look forward to helping to sustainably drive the company’s growth and performance,” says Martin Löffler, SVP, CFO Diaverum.
Dr. Claus Biermann – international industry expert
“I am very pleased to be working in this fast-growing company and to be paving the way towards integrated services in nephrology together. A key success factor will be the successful implementation of an Integrated Renal Care strategy. An expansion of the current scope towards health economics and health policy affairs is a necessary prerequisite for this,” says Dr. Claus Biermann, SVP, Chief Strategy & Health Policy Affairs Officer at Diaverum.
Before joining Diaverum in January 2015, Dr. Claus W. Biermann works as a global executive healthcare consultant and entrepreneur. He began his career in 1990 in medical, quality and research-related roles at the University Hospitals of Hamburg, Bochum, Münster, Aarhus and Chicago. He then worked in various top management positions in the healthcare industry at Janssen-Cilag Germany / Europe, Grünenthal, Coss AG and T-Systems International. In 2006 he joined Royal Philips Electronics as Vice President Global Business Development and Chief Medical Officer Health Emerging Markets Healthcare, and in 2012 he took on the role of Executive Director Market Development & Innovation at GE Healthcare Germany / Europe. Dr. Claus Biermann is a general practitioner (MD) and has a Master in Public Health (MPH) from Bielefeld University, Germany.